by Jordana Choucair | Jun 30, 2022 | Life Sciences
The Biden administration announced that it will purchase 105 million doses of an updated Pfizer COVID-19 vaccine, pending Food and Drug Administration (FDA) approval. The updated vaccine is expected to target the omicron variant, with the goal of providing improved...
by Jordana Choucair | Jun 30, 2022 | Life Sciences
Pfizer and BioNTech announced they will initiate clinical trials of pan-coronavirus vaccines in the second half of the year. The company said it wants to provide “durable variant protection.” Universal vaccines have been studied with limited success for...
by Jordana Choucair | Jun 30, 2022 | Payers
A new Brookings Institute analysis found that eliminating premiums for low-income Affordable Care Act exchange customers that pay a very small amount a month could boost coverage by 48,000 this year. According to the analysis, even requiring customers to pay even a...
by Jordana Choucair | Jun 30, 2022 | Payers
Banner Health, Hue Health, and Flume Health launched a new health plan built around direct primary care. The 39 North plan, which was created by Hue Health and Banner Health, will be available to all employers in northern Colorado and, in addition to Hue’s...
by Jordana Choucair | Jun 29, 2022 | D.C. News
Health and Human Services (HHS) Secretary Xavier Becerra urged patience as his department reviews its options to counter the Supreme Court’s abortion decision. Acknowledging that there is “no magic bullet,” Becerra said the department is focusing on five areas: 1)...
by Jordana Choucair | Jun 29, 2022 | Life Sciences
An expert advisory vaccine panel for the Food and Drug Administration (FDA) recommended updated COVID-19 vaccines specifically designed to combat the omicron variant. Nineteen members of the Vaccines and Related Biological Products Advisory Committee voted in favor of...
Recent Comments